Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07042074 · ClinicalTrials.gov registry record · NA
Use of Augmented Reality and Virtual Reality During Cognitive Behavioral Therapy for Needle Phobia
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07042074: Clinical Trial NA study, sponsored by Stanford University.
NCT07042074 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07042074, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This case series study seeks to evaluate the use of a Spatial Computing Device and Augmented Reality (AR) and Virtual Reality (VR) as an exposure therapy modality for children and adolescents with needle and blood-injection-injury phobia. This study will take place at Lucile Packard Children's Hospital (LPCH) and Stanford Hospital (Stanford University, Palo Alto, CA).
Interventions
- BEHAVIORAL Mixed reality (XR) Exposure Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07042074
The ClinicalTrials.gov registry entry for NCT07042074 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mixed reality (XR) Exposure Therapy is the first listed.
NCT07042074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07042074 about?
NCT07042074 is a clinical study titled "Use of Augmented Reality and Virtual Reality During Cognitive Behavioral Therapy for Needle Phobia". This case series study seeks to evaluate the use of a Spatial Computing Device and Augmented Reality (AR) and Virtual Reality (VR) as an exposure therapy modality for children and adolescents with needle and blood-injection-injury phobia. This study will take place at Lucile Packard Children's Hospi...
What is the current status of trial NCT07042074?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-05-01. Estimated completion is 2027-04-30.
What interventions are being tested in trial NCT07042074?
The interventions under investigation include: Mixed reality (XR) Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07042074?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.